Navigation Links
John McEnroe is Serious About Getting Men to Take the '50 Over 50 Prostate Health Challenge'
Date:3/16/2009

PHILADELPHIA, March 16 /PRNewswire/ -- Three-time Wimbledon and four-time US Open Champion John McEnroe has teamed up with GlaxoSmithKline (NYSE: GSK) to create a public-education initiative entitled the "50 Over 50 Prostate Health Challenge."

Fifty percent of men over 50 years of age have an enlarging prostate; if left untreated it can lead to worsening urinary symptoms and even prostate-related surgery.

"I just celebrated my 50th birthday, and while I'm still as active as ever, I know there are certain health issues I need to stay on top of, including my prostate health," said McEnroe. "Now I'm asking other men to take the '50 Over 50 Prostate Health Challenge.' It's all about talking to your doctor and getting serious about your prostate health."

As a part of the campaign, an interactive web site, www.50over50challenge.com, has been created where men can start the "Prostate Health Challenge." The challenge is to take three easy steps to get serious about prostate health: a brief online prostate health assessment; seeing a doctor for a prostate-health exam; and knowing your PSA (Prostate-specific antigen) level. PSA level, obtained from a simple blood test, is a protein marker that can rise when a prostate condition is present.

McEnroe will also be featured in public education video messages that will appear throughout the year on network television, internet sites and at 50over50challenge.com. The first video vignette will air on April 4 in between the first and second games of the men's college basketball semi final on CBS. There will also be national print messages in March and April running in such publications as USA Today, Sports Illustrated, Time and Newsweek.

"Prostate health can be awkward to talk about, so we've created a series of hopefully memorable, vignettes to help get men talking. I am hoping my involvement will be motivational and encourage men to take the Challenge and take control of their prostate health," added McEnroe.

About Enlarging Prostate

Enlarging prostate is a prevalent and progressive condition that affects approximately 50 percent of men over 50 years of age and over 90 percent of men older than age 80. An enlarged prostate can cause changes in urinary habits because of its location around the urethra. Over time, the prostate can continue to grow and urinary symptoms may worsen as the bladder loses the ability to empty itself. Left untreated, in severe cases, an enlarged prostate can lead to serious long-term problems including acute urinary retention (AUR) and the need for prostate-related surgery.

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.


'/>"/>
SOURCE GlaxoSmithKline
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Superstar John McEnroe to Highlight The Kennedy Funding Invitational Tennis Tournament, July 9-13, 2008
2. Local Communities Get Serious About Saving Lives Through Project Lifesaver Tracking Equipment, Says NAA
3. New Texas Study Reveals Serious Flaws in Abstinence Programs
4. Harmonix Music Systems, Inc. and MTV Games Make a Donation to Starlight and Bring Rock Band(R) to Thousands of Seriously Ill Children
5. IMPACT Study Demonstrates That Longer Prophylactic Therapy With Valcyte(R) (Valganciclovir Hydrochloride Tablets) Increases Protection Against CMV - the Most Serious Viral Infection Affecting Transplant Patients
6. Sexual health promotion is low among people with serious mental illnesses, despite higher risk
7. Pharmaceuticals sold in Sweden cause serious environmental harm in India
8. Physical activity, mood and serious mental illness
9. AFB Survey Finds Drug Labeling Puts People with Vision Loss at Serious Medical Risk
10. Late preterm births present serious risks to newborns
11. Americans Want Schools to Take Recess Seriously
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... An educational campaign ... inspiring human-interest stories, courtesy of awareness-driven celebrities and thought leaders. It also provides ... associations and industry leaders such as Bioness. , As patients feel increasingly ...
(Date:5/27/2016)... ... 2016 , ... Aimed at nurses and employees in the health care world, ... in the nursing and health care industry. It also provides insight to the developing ... , As the nursing industry is coming out of one of the biggest ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... There are ... Hot Dog and Sausage Council (NHDSC) suggests that Americans prefer their dogs straight off ... 63 percent say grilling is their favorite way to cook a hot dog, far ...
(Date:5/26/2016)... ... 2016 , ... Georgia State University College of Law is ... Answering to the increasing demand for curricular specializations, the Certificate in Intellectual Property ... land use law. ,  , “The demand for lawyers with specific knowledge in ...
(Date:5/26/2016)... ... 2016 , ... Cardiac arrhythmia is a common complication following ... survival, reports a team of UPMC researchers in the largest study of its ... Thoracic and Cardiovascular Surgery, provide critical information that will hopefully lead to better ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... -- The healthcare sector is large and ... falling under its umbrella.  A rather overlooked sector are ... about, these healthcare companies are still trying to prove ... by far the largest consumer of the healthcare market ... Nutranomics Inc. (OTC: NNRX), KollagenX Corp. (OTCQB: KGNX), Bioelectronics ...
(Date:5/26/2016)... -- TARE (Transarterial Radio-embolization) Using Yttrium-90 ... Overall Decreased Use of Hospital Resource ... healthcare company, has today announced the publication of ... ISPOR (International Society for Pharmacoeconomics and Outcomes Research), ... yttrium-90 glass microspheres is associated with cost savings ...
(Date:5/25/2016)... 25,2016 FDA 510(k) clearance ... platform for urological and surgical applications ... of Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) ... the US with the 12 th 510(k) ... (FDA). This new FDA clearance covers Confocal Miniprobes ...
Breaking Medicine Technology: